Emblok Overview
- Year Founded
-
2012
- Status
-
Private
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
8
Emblok General Information
Description
Manufacturer of an embolic protection system designed to offer protection from material released during left-sided cardiovascular procedures. The company's system is utilized in transaortic valve replacement (TAVR) procedures and other left heart interventional procedures where protection is required, and also lets multiple devices be deployed in a single femoral puncture site, enabling patients to improve the quality of their life and lower overall healthcare costs associated with risks.
Contact Information
Website
www.emblok.comCorporate Office
- 410 South Cedar Avenue
- Tampa, FL 33606
- United States
Corporate Office
- 410 South Cedar Avenue
- Tampa, FL 33606
- United States
Emblok Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Emblok Comparisons
Industry
Financing
Details
Emblok Competitors (11)
One of Emblok’s 11 competitors is Emboline, a Venture Capital-Backed company based in Santa Cruz, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Emboline | Venture Capital-Backed | Santa Cruz, CA | ||||
| Open Stent Solution | Venture Capital-Backed | Amiens, France | ||||
| Artio | Venture Capital-Backed | Prairie Village, KS | ||||
| Instylla | Venture Capital-Backed | Bedford, MA | ||||
| Bendit | Venture Capital-Backed | Petah Tikva, Israel |
Emblok Patents
Emblok Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019231663-A1 | Embolic protection device | Active | 07-Mar-2018 | ||
| AU-2019231663-B2 | Embolic protection device | Active | 07-Mar-2018 | ||
| AU-2025202800-A1 | Embolic protection device | Pending | 07-Mar-2018 | ||
| CA-3092870-A1 | Embolic protection device | Pending | 07-Mar-2018 | ||
| EP-3761902-A1 | Embolic protection device | Pending | 07-Mar-2018 | A61F2/0105 |
Emblok Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Emblok FAQs
-
When was Emblok founded?
Emblok was founded in 2012.
-
Where is Emblok headquartered?
Emblok is headquartered in Tampa, FL.
-
What industry is Emblok in?
Emblok’s primary industry is Surgical Devices.
-
Is Emblok a private or public company?
Emblok is a Private company.
-
What is Emblok’s current revenue?
The current revenue for Emblok is .
-
How much funding has Emblok raised over time?
Emblok has raised $24M.
-
Who are Emblok’s investors?
JSTAR Capital has invested in Emblok.
-
Who are Emblok’s competitors?
Emboline, Open Stent Solution, Artio, Instylla, and Bendit are some of the 11 competitors of Emblok.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process